ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,271.69
0.16%
Dow Jones
44,860.31
0.28%
Gold vs US Dollar
2,649.365
0.65%
Brent Oil
72.47
0.03%
Bitcoin
93,298.54
1.44%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Dianthus Therapeutics Inc (DNTH)

  7. Dianthus Therapeutics Inc (DNTH) News

Dianthus Therapeutics (DNTH)

Dianthus Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DNTH
DateTimeSourceHeadlineSymbolCompany
07/11/202421:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
04/11/202412:00GlobeNewswire Inc.Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor ConferencesNASDAQ:DNTHDianthus Therapeutics Inc
15/10/202411:00GlobeNewswire Inc.Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
04/09/202411:00GlobeNewswire Inc.Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in SeptemberNASDAQ:DNTHDianthus Therapeutics Inc
08/08/202420:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
28/06/202415:30GlobeNewswire Inc.Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)NASDAQ:DNTHDianthus Therapeutics Inc
12/06/202411:00GlobeNewswire Inc.Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)NASDAQ:DNTHDianthus Therapeutics Inc
30/05/202420:30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
09/05/202420:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
08/05/202420:30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
03/05/202420:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
11/04/202411:30GlobeNewswire Inc.Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
05/04/202420:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
21/03/202420:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
07/03/202421:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
26/02/202412:00GlobeNewswire Inc.Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)NASDAQ:DNTHDianthus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DNTH

Your Recent History

USOTC
KGSPY
Kingspan (PK)
BIT
P1KOC7
BNP Paribas Issuance
FX
AUDMAD
AUD vs MAD
NASDAQ
VGAS
Verde Clean Fuels
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Silver

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £903.96 only 361.58